Zobrazeno 1 - 10
of 13 519
pro vyhledávání: '"IgA nephropathy"'
Autor:
Hyeon Tae Yang, Tae In Park, Yong-Jin Kim, Mee-seon Kim, Sun-Hee Park, Jeong-Hoon Lim, Yoo Na Kang, DongJa Kim, Man-Hoon Han
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Immunoglobulin A nephropathy (IgAN) is the predominant primary glomerulonephritis globally and remains a subject of active research with a focus on understanding its course and prognosis. Although vascular lesions are associated w
Externí odkaz:
https://doaj.org/article/397dd83bac6948e4823554dd5019f309
Autor:
Wenqiang Zhi, Aizhong Li, Qian Wang, Xiaoli Yuan, Jianbo Qing, Caixiang Zhang, Yuxin Wang, Yafeng Li
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract To assess the safety and efficacy of fecal microbiota transplantation (FMT) as an adjunctive therapeutic intervention for IgA nephropathy (IgAN). Fifteen patients with IgA nephropathy were recruited based on inclusion and exclusion criteria
Externí odkaz:
https://doaj.org/article/b3a395dbd47549cd862edebf1bf22dad
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract Background Behcet’s disease (BD) is an inflammatory disorder of unknown cause that is characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Local vasculitis can cause damage to the visceral system, but
Externí odkaz:
https://doaj.org/article/56cc8c7c1a6e4572b9058828641c760b
Autor:
Ahmed A. Abo Elnaga, Mohamed A. Alsaied, Abdelrahman M. Elettreby, Alaa Ramadan, Mohamed Abouzid, Raghda Shetta, Yazan A. Al-Ajlouni
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Sparsentan has shown positive effects on managing different subtypes of glomerulonephritis. The recent results of trials require a pooled analysis to validate these results. Aim We aim to assess the safety and efficacy of sparsent
Externí odkaz:
https://doaj.org/article/6b443702776f4154a5a2dc579fbf8135
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Patients diagnosed with IgA nephropathy (IgAN) commonly experience a substantial burden of symptoms encompassing both physical and psychological aspects. Presently, there's a dearth of standardized assessment tools to effectively gauge the e
Externí odkaz:
https://doaj.org/article/b0fd2528f2f54865bc59dee422d1b5c4
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Purpose The purpose of this study was to investigate the correlation between podocyte related biomarker cofilin-1 and renal function, and explore the value of cofilin-1 in predicting the risk of renal adverse prognosis in IgA nephropathy (Ig
Externí odkaz:
https://doaj.org/article/d4d8d2a9642f41488020f51f4595d2d1
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 5943-5955 (2024)
Yan Tang,1,* Xiaoling Liu,1,* Wang Zhou,2 Xiachuan Qin3 1Department of Ultrasound, Beijing Anzhen Hospital Nanchong Hospital, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College (University), Nan Chon
Externí odkaz:
https://doaj.org/article/b2ecee90442c4aae864b8b30b7d3abff
Publikováno v:
Linchuang shenzangbing zazhi, Vol 24, Iss 8, Pp 681-686 (2024)
As one of the most common primary glomerulopathies, immunoglobulin A nephropathy(IgAN) is a major cause of end-stage renal disease (ESRD). Its proper treatment has remained rather challenging. Disease progression may be delayed if associated
Externí odkaz:
https://doaj.org/article/92c24ce91fcb4ccb87439f68feba8fc7
Autor:
Jing Li, Yang Shen, Kaixin Yan, Siyuan Wang, Jie Jiao, Hongjie Chi, Jiu-chang Zhong, Ying Dong, Pan Wang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background The prevalence of chronic kidney disease (CKD) is on the rise, posing a significant public health challenge. Although gut microbiome dysbiosis has been implicated in the impairment of kidney functions, the existence of pathologica
Externí odkaz:
https://doaj.org/article/649cc9f86e964b308ecd5b564aa83f06